Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Celadon Pharma. (CEL)

Price 59.50p on 19-07-2024 at 16:30:02
Change 3.50p 6.25%
Buy 62.00p
Sell 57.00p
Buy / Sell CEL Shares
Last Trade: Unknown 23,287.00 at 59.75p
Day's Volume: 42,742
Last Close: 59.50p
Open: 56.00p
ISIN: GB00BDQYGP38
Day's Range 57.50p - 61.00p
52wk Range: 50.00p - 153.00p
Market Capitalisation: £39m
VWAP: 59.69668p
Shares in Issue: 66m

Recent Trades History Celadon Pharma. (CEL)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 23,287 59.75p Ordinary
14:16:11 - 19-Jul-24
Buy* 293 61.70p Ordinary
14:54:58 - 19-Jul-24
Buy* 2,880 61.70p Ordinary
14:40:35 - 19-Jul-24
Buy* 2,000 61.70p Ordinary
14:27:00 - 19-Jul-24
Buy* 1,750 61.6675p Suspected BUY Trade
14:25:01 - 19-Jul-24
Buy* 2,750 61.00p Ordinary
14:24:10 - 19-Jul-24
Buy* 1,499 59.40p Suspected BUY Trade
13:00:27 - 19-Jul-24
Buy* 418 59.70p Suspected BUY Trade
12:55:58 - 19-Jul-24
Buy* 3,000 58.249p Ordinary
12:42:05 - 19-Jul-24
Buy* 2,000 57.00p Ordinary
12:41:10 - 19-Jul-24

Share Price History for Celadon Pharma.

Time period:
to
Date Open High Low Close Volume

Share News for Celadon Pharma.

EARNINGS AND TRADING: Gateley earnings fall; 4Global revenue rises

16th Jul 2024 19:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

20th Jun 2024 15:48

Read More

TRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pact

23rd May 2024 21:08

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More

TRADING UPDATES: Headlam warns of loss; EnSilica predicts revenue rise

14th May 2024 19:41

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Celadon raises GBP2 million, extends credit facility

10th May 2024 18:57

Celadon Pharmaceuticals PLC - London-based pharmaceutical company focused on the development, production and sale of breakthrough cannabis-based medicines - Raises GBP2.1 million via placing and subscription of 2.0 million shares at 105 pence each. Further, confirms it has extended the expiry date of its GBP7 million committed credit facility, entered into in May 2023, from May 30, 2025 to November 30, 2025, on the same terms as announced in 2023. Proceeds of the fundraise will provide additional working capital. With the fundraise and credit facility, Celadon says it has the working capital available that will be sufficient for its present requirements, that is for at least 12 months. As a result, it has decided not to pursue convertible loan notes financing. Read More

FTSE 100 Latest
Value8,155.72
Change-49.17

Login to your account

Forgot Password?

Not Registered